FDA NOT RECOMMENDING METFORMIN RECALL
ecently, we wrote that the U.S. Food and Drug Administration (FDA) was testing batches of the type 2 diabetes drug metformin for a potential contaminant. This contaminant, N-nitrosodimethylamine—more commonly known
